Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,166.00
Bid: 12,164.00
Ask: 12,166.00
Change: 104.00 (0.86%)
Spread: 2.00 (0.016%)
Open: 12,194.00
High: 12,266.00
Low: 12,054.00
Prev. Close: 12,062.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK EXECUTIVE CHANGE SUMMARY: Wizz Poaches From easyJet; New Cenkos CEO

Wed, 09th Dec 2020 16:08

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Wednesday and not separately reported by Alliance News:

----------

Wizz Air Holdings PLC - Budapest-based budget airline - Hires Robert Carey as president, starting June 14 next year, to oversee operations and commercial functions. Carey has been chief commercial & strategy officer for rival carrier easyJet PLC since 2017, having started at America West Airlines followed by Delta Airlines and a 10-year stint at McKinsey & Co. Wizz also hires Michael Delehant as executive vice president and chief operations officer, reporting to Carey. Delehant joins from Vueling, the Spanish low-cost airline owned by International Consolidated Airlines Group SA, where he has been chief strategy & network officer. He starts at Wizz on April 1.

----------

Cenkos Securities PLC - London-based stock broker and company advisor - Jim Durkin will retire as chief executive in March of next year, after having returned to Cenkos in 2019. That was a difficult time for UK stockbrokers, Cenkos notes, and Durkin "kept the company profitable, led the restructuring of the board and further strengthened governance". Julian Morse, an executive director and head of the Growth Companies Team, will replace Durkin as CEO. Cenkos says Morse is a founding member of the Growth Companies Team and has led it since 2016. Cenkos also promotes Jeremy Osler, co-head of Corporate Finance & general counsel, to the board as an executive director. Osler joined Cenkos in 2016.

----------

London Stock Exchange Group PLC - trading and clearing operator and index calculator - Proposes Martin Brand, Erin Brown and Douglas Steenland as board directors. The appointments are part of LSEG's acquisition of market data and trading platform provider Refinitiv, following which the shareholders of Refinitiv will have the right to nominate three non-executive directors for as long as they continue to hold at least 25% of LSEG. Brand and Steenland will represent Blackstone, and Brown will represent Thomson Reuters. Brand is a senior managing director and co-head of US Acquisitions for Blackstone's Private Equity Group. Steenland is a a senior adviser to the Blackstone Private Equity Group. Brown is head of Finance for the Thomson Reuters Corporates segment. LSEG expects the Refinitiv acquisition to complete in the first quarter of next year.

----------

Aviva PLC - London-based life and general insurer - Hires Pippa Lambert as independent non-executive director, starting January 1. Lambert was global head of Human Resources at Deutsche Bank AG and before that head of Reward at Royal Bank of Scotland.

----------

OptiBiotix Health PLC - York, England-based developer of compounds to treat obesity, high cholesterol, diabetes and skincare - Hires Christopher Brinsmead as director. Brinsmead was president of AstraZeneca UK & Ireland, part of AstraZeneca PLC, until 2010 and before that president of the Association of the British Pharamaceutical Industry.

----------

Network International Holdings PLC - Middle East-focused payment solutions provider - Hires Diane Radley and Monique Shivanandan as independent non-executive directors, starting January 1. Radley led the Transaction Services Group at PwC South Africa. She also was CEO of Old Mutual Investment Group from 2011 to 2016, having been finance director prior to that. Shivanandan is chief information officer at property and casualty insurance firm Chubb Ltd and also a non-executive director for JP Morgan Securities in the UK.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more
4 Apr 2024 13:09

UK shareholder meetings calendar - next 7 days

Friday 5 April 
Faron Pharmaceuticals LtdAGM
VPC Specialty Lending Investments PLCGM re capital return via B share scheme
Monday 8 April 
Premier African Minerals LtdAGM
Tuesday 9 April 
Ethernity Networks LtdEGM re board appointments and option grants
Wednesday 10 April 
Valereum PLCAGM
Wincanton PLCGM re takeover by GXO Logistics Inc
Thursday 11 April 
AstraZeneca PLCAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
3 Apr 2024 22:01

Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs

WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.

Read more
3 Apr 2024 17:22

UK's FTSE 100 pressured by stronger pound; miners climb

FTSE 100 flat, FTSE 250 up 0.2%

*

Read more
3 Apr 2024 11:02

CORRECT: AstraZeneca, Daiichi make US progress with licence approvals

(Correcting the description of extravascular haemolysis' effects on patients with paroxysmal nocturnal haemoglobinuria)

Read more
2 Apr 2024 15:22

London close: Stocks turn red on return from Easter break

(Sharecast News) - UK stocks experienced a downturn by the end of trading on Tuesday, as investors resumed activity following the extended weekend, with initial gains reversed by the close ahead of a week marked by a number of key economic data releases.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.